Browsing Centre for Cancer Prevention by Title
Now showing items 758-777 of 1181
-
P53 IMMUNOHISTOCHEMISTRY AS A SURROGATE FOR TP53 MUTATIONAL ANALYSIS IN ENDOMETRIAL CANCER BIOPSIES
(2018-09)Meeting abstract from 17th Biennial Meeting of the International Gynecologic Cancer Society Kyoto, Japan September 14-16, 2018 -
Pancreatic cancer: a glimmer of hope
(2023) -
Parenclitic networks for predicting ovarian cancer.
(2018-04-27)Prediction and diagnosis of complex disease may not always be possible with a small number of biomarkers. Modern 'omics' technologies make it possible to cheaply and quantitatively assay hundreds of molecules generating ... -
Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.
(2014-09)GTP cyclohydrolase 1, encoded by the GCH1 gene, is an essential enzyme for dopamine production in nigrostriatal cells. Loss-of-function mutations in GCH1 result in severe reduction of dopamine synthesis in nigrostriatal ... -
Participant-reported symptoms as predictors of long-term adherence of endocrine therapy in the International breast cancer intervention studies 2 (IBIS-2)
(American Association for Cancer Research, 2018-02)Background: Aromatase inhibitors (AIs) reduce the risk of breast cancer in women at increased risk and reduce recurrence in those with ductal carcinoma in situ (DCIS) (IBIS-2, MAP.3, NSABP B-33). The effectiveness of AIs ... -
Patient barriers and facilitators of colonoscopy use: A rapid systematic review and thematic synthesis of the qualitative literature.
(Elsevier Inc., 2021-01-04)Colonoscopy is the gold standard test in the diagnosis of colorectal cancer. Despite this, many people across the world decline the procedure when invited for screening, surveillance or diagnostic evaluation. The aim of ... -
Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study.
(Wiley, 2023-09-26)OBJECTIVE: To evaluate patient preference for short (gist) or detailed/extensive decision aids (DA) for genetic testing at ovarian cancer (OC) diagnosis. DESIGN: Cohort study set within recruitment to the Systematic Genetic ...